ULTRIS 1 mg TABLETAS
Country: Venezuela
Language: Spanish
Source: Instituto Nacional de Higiene
Patient Information leaflet
(PIL)
18-12-2023
Public Assessment Report
(PAR)
18-12-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
REPAGLINIDA
Available from:
GLENMARK PHARMACEUTICALS VENEZUELA, C.A.
INN (International Name):
REPAGLINIDA 1 MG
Dosage:
1 mg
Pharmaceutical form:
TABLETA
Administration route:
ORAL
Prescription type:
CON PRESCRIPCION FACULTATIVA
Manufactured by:
GLENMARK GENERIES Ltd.
Authorization status:
VENCIDO
Authorization date:
2018-02-28
